Belinostat (PXD101)

Belinostat (PXD101)

Catalog Number:
L002369009APE
Mfr. No.:
APE-A4096
Price:
$212
  • Size:
    Quantity:
    Add to Cart:
      • Overview
        • Please contact us at for specific academic pricing.

          Background

          Belinostat (also known as PXD101) is a novel and potent hydroxamate-type inhibitor of histone deacetylase (HDAC) that inhibits the activity of HDAC in Hela cell extracts with 50% inhibition concentration IC50 value of 27 nM. Belinostat has been found to significantly increase the acetylation of histones H3 and H4 and exerts cytotoxicity in a wide range of tumor cell lines. In the treatment of urothelial carcinoma cell lines, belinostat dose-dependently inhibits proliferation in 5637, T24, J82 and RT4 cells with IC50 values of 1.0 μM, 3.5 μM, 6.0 μM and 10 μM respectively; while, in prostate cancer cell lines, it inhibits cancer cell growth with IC50 values ranging from 0.5 to 2.5 μM.

      • Properties
        • Alternative Name
          PXD-101, PXD 101, PX105684, PX-105684; (E)-N-hydroxy-3-[3-(phenylsulfamoyl)phenyl]prop-2-enamide
          CAS Number
          414864-00-9
          Molecular Formula
          C15H14N2O4S
          Molecular Weight
          318.35
          Appearance
          A solid
          Purity
          99.10%
          Solubility
          insoluble in H2O; ≥15.92 mg/mL in DMSO; ≥44.1 mg/mL in EtOH with ultrasonic
          Storage
          Store at -20°C

          * For Research Use Only

      • Reference
        • 1. Bagnall NH, Hines BM, et al. "Insecticidal activities of histone deacetylase inhibitors against a dipteran parasite of sheep, Lucilia cuprina." Int J Parasitol Drugs Drug Resist. 2017 Apr;7(1):51-60. PMID:28110187
          2. Hai Y, Christianson DW. "Histone deacetylase 6 structure and molecular basis of catalysis and inhibition." Nat Chem Biol. 2016 Jul 25. PMID:27454933

    Note: If you don't receive our verification email, do the following:

    Copyright © Amerigo Scientific. All rights reserved.